Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Rivaroxaban may cause hair loss.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Ozenoxacin reduces sebum production, helping manage acne.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The treatment cleared psoriasis in some patients but caused side effects in most.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Topical Ruxolitinib may safely treat severe hair loss.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

RXRα is crucial for proper immune response and links diet to immune function.